KEPHAS PHARMA
ActiveSummary
KEPHAS PHARMA has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €33,505 and a net result of €7,346. Its solvency ranks better than 72% of 25,598 sector peers (NACE 47, financial year 2024). The computed 12-month bankruptcy probability is 1.4% (low).
Register details
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 11 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
1 establishment unit
1 parcel
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 52042C0120/00C005 | Wallonia | 431 m² | 1 · 157 m² | 10.4 m · 3 |